What is the stock price of AstraZeneca plc?

AstraZeneca PLC: Reaffirming HOLD following 1Q results Symbols AZN Sector(s) Healthcare Rating Current Price $66.92 Price Target Earnings Estimate Summary AstraZeneca is a British-Swedish company with its main headquarters in the U.K. and regional headquarters in Sweden and the U.S.

Is AstraZeneca falling behind us and China in biotech?

UK and Europe are falling behind US and China in biotech, says AstraZeneca boss AstraZeneca confident new COVID antibody protects against known variants AstraZeneca hunts for more China deals after signing partnerships AstraZeneca (AZN) to Report Q1 Earnings: What's in the Cards? Fiscal Q1 2023 ended 3/31/23. Reported on 4/27/23.

Why did AstraZeneca report strong second-quarter results?

AstraZeneca reported strong second-quarter results largely in line with our projections and consistent with our fair value estimate. The results included a one-time gain from the rearrangement of the deal with Sanofi and Sobi for respiratory syncytial virus treatment Beyfortus, which led to a bolus in earnings growth that will not likely recur.

What does AstraZeneca do?

The Company, through its subsidiaries, researches, manufactures, and sells pharmaceutical and medical products. AstraZeneca focuses its operations on eight therapeutic areas, including gastrointestinal, oncology, cardiovascular, respiratory, central nervous system, pain control, anaesthesia, and infection.